Provider-supervised catalog
GLP-1 and dual GIP/GLP-1 medications such as semaglutide and compounded tirzepatide act on the gut-hormone pathways that influence appetite and blood-sugar regulation. Every option below shows its exact strength and price up front, and is prescribed only after an independent, licensed U.S. provider reviews your medical intake. These are prescription products, not over-the-counter supplements.
6 treatments
Compounded Injectable Vial
A compounded dual GIP/GLP-1 injectable for medically supervised weight management. Prescribed only after a licensed provider reviews your health intake.
Adjustable dose · 2.5–20 mg/mL
from $138.29
Choose dose
Lipotropic Injectable — 30 mL
An injectable blend of B vitamins and MIC lipotropic compounds, used as a supportive add-on within supervised weight management plans. Prescription only.
Adjustable dose · 5–50 mL
from $43.60
Choose dose
Lipotropic + B12 Injectable — 30 mL
A lipotropic injection combining MIC compounds with vitamin B12, used as a supportive part of supervised weight management plans. Prescription only.
Adjustable dose · 10–50 mL
from $35.60
Choose dose
Compounded GLP-1 Injectable — coming soon
A GLP-1 injectable for weight management — launching soon at OpenDoseRx, dispensed after licensed provider review.
Launching soon
View details
LDN 0.1–4.5 mg Capsules
Naltrexone in low-strength capsules, prescribed off-label as an adjunct in some weight management plans. Dispensed only after licensed provider review.
11 strengths available
from $79.00
Choose options
Ondansetron 4–8 mg Tablets
A prescription anti-nausea tablet often used to manage treatment-related nausea, including during GLP-1 therapy. Provider review required before dispensing.
2 strengths available
from $39.00
Choose optionsSemaglutide vs. tirzepatide: how GLP-1 and GIP/GLP-1 medications differ
A neutral, mechanism-focused comparison of two prescription incretin medications and the gut-hormone receptors they act on.
How GLP-1 medications interact with appetite and digestion
A neutral, mechanism-focused look at how GLP-1 receptor agonism engages the gut-brain satiety axis and the gastric-emptying signals tied to hunger and fullness.
Oral vs. injectable GLP-1 medications: how the routes differ
A neutral, mechanism-focused look at how injecting a GLP-1 peptide under the skin and absorbing one by mouth differ in absorption and bioavailability.
How ondansetron (Zofran) is understood to work: the 5-HT3 pathway
A plain-language look at how ondansetron, an antiemetic often discussed alongside GLP-1 tolerability, is understood to act on the serotonin 5-HT3 pathway in the gut and brainstem.
What lipotropic injections are: MIC, B12, and the ingredients explained
A plain-language look at what lipotropic "MIC" blends are and the metabolic roles attributed to methionine, inositol, choline, and vitamin B12 — the components in lipo-mino and lipo-b.
Leptin and ghrelin: how the body's hunger and fullness hormones work
A neutral, mechanism-focused look at how two opposing hormones — leptin from fat tissue and ghrelin from the stomach — are understood to relay energy status to the brain's appetite centers.
How the body stores and burns fat: lipogenesis and lipolysis
A plain-language look at the two opposing processes the body is understood to use to store energy as fat and release it again, and the hormones that tip the balance between them.
Metabolic adaptation: how the body is understood to defend its weight set point
A plain-language, mechanism-focused look at how the body is understood to defend a weight range through adaptive thermogenesis and shifts in appetite-signaling hormones.
